首页 | 本学科首页   官方微博 | 高级检索  
检索        

医院获得性与社区获得性耐甲氧西林金黄色葡萄球菌耐药性差异
引用本文:牛瑞兵,郭利平,王新刚,段宝生,巴特尔.医院获得性与社区获得性耐甲氧西林金黄色葡萄球菌耐药性差异[J].中国感染控制杂志,2015,14(7):476-478.
作者姓名:牛瑞兵  郭利平  王新刚  段宝生  巴特尔
作者单位:医院获得性与社区获得性耐甲氧西林金黄色葡萄球菌耐药性差异
基金项目:

内蒙古自治区卫生和计划生育委员会医疗卫生科研计划项目(201302161)

摘    要:目的对比分析某院医院获得性与社区获得性耐甲氧西林金黄色葡萄球菌(MRSA)的耐药性,为临床治疗和合理应用抗菌药物提供参考。方法收集并分析2013年5月—2014年6月某院分离的金黄色葡萄球菌,采用VITEK2 Compact全自动微生物鉴定仪及药敏系统进行鉴定和药物敏感性试验,并结合临床资料进行医院与社区获得性感染的诊断。结果共分离MRSA84株(医院获得性61株、社区获得性23株),医院获得性与社区获得性MRSA对青霉素G、苯唑西林的耐药率均为100.00%;对氨苄西林/舒巴坦的耐药率分别为100.00%和95.65%;对复方磺胺甲口恶唑的耐药率分别为39.34%和34.78%。医院获得性MRSA对庆大霉素、四环素、红霉素、克林霉素、左氧氟沙星、环丙沙星、莫西沙星、呋喃妥因、利福平的耐药率均高于社区获得性MRSA,差异均有统计学意义(均P0.001)。结论医院获得性与社区获得性MRSA的耐药性均比较严重,应加强监测,临床治疗中要根据药敏试验合理选择抗菌药物。

关 键 词:医院感染  社区感染  金黄色葡萄球菌  耐甲氧西林金黄色葡萄球菌  抗药性  微生物    合理用药  
收稿时间:2014-12-20
修稿时间:2015/2/12 0:00:00

Difference in antimicrobial resistance between hospital and community associated methicillin resistant Staphylococcus aureus
NIU Rui bing,GUO Li ping,WANG Xin gang,DUAN Bao sheng,BA Te er.Difference in antimicrobial resistance between hospital and community associated methicillin resistant Staphylococcus aureus[J].Chinese Journal of Infection Control,2015,14(7):476-478.
Authors:NIU Rui bing  GUO Li ping  WANG Xin gang  DUAN Bao sheng  BA Te er
Institution:Ordos Central Hospital, Ordos, Inner Mongolia 017000,China
Abstract:ObjectiveTo analyze antimicrobial resistance of hospital associated methicillin resistant Staphylococcus aureus(HA MRSA) and community associated methicillin resistant Staphylococcus aureus (CA MRSA), and provide reference for clinical treatment and rational antimicrobial use.MethodsFrom May 2013 to June 2014, Staphylococcus aureus in a hospital were collected and analyzed, strains were identified and performed antimicrobial susceptibility testing by using VITEK 2 Compact system, diagnosis of HA MRSA and CA MRSA were confirmed in combined with clinical symptoms.ResultsA total of 84 MRSA isolates were isolated (61 were HA MRSA strains, 23 were CA MRSA).Resistant rates of HA MRSA and CA MRSA to penicillin G and oxacillin were both 100.00%; to ampicillin/sulbactam was 100.00% and 95.65% respectively; to compound sulfamethoxazole was 39.34% and 34.78% respectively. Antimicrobial resistant rates of HA MRSA to gentamicin, tetracycline, erythromycin, clindamycin, levofloxacin,ciprofloxacin, moxifloxacin, nitrofurantoin, and rifampicin were all higher than CA MRSA, the difference were significant(all P<0.001).ConclusionAntimicrobial resistance of HA MRSA and CA MRSA are all serious, monitor should be intensified, antimicrobial use should be chosen according to antimicrobial susceptibility testing result.
Keywords:healthcare associated infection  community associated infection  Staphylococcus aureus  methicillin resistant Staphylococcus aureus  drug resistance  microbial  rational drug use  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号